Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperuricemia and associated diseases.

Michael A Becker1, Meenakshi Jolly

  • 1Rheumatology Section, The University of Chicago Pritzker School of Medicine, Chicago, IL, USA. mbecker@medicine.bsd.uchicago.edu

Rheumatic Diseases Clinics of North America
|May 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the readability and comprehension of patient education materials for Systemic Lupus Erythematosus (SLE) available online.

Lupus·2026
Same author

New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16-17 October 2024.

Lupus science & medicine·2025
Same author

Not So Patient Friendly: Patient Education Materials in Rheumatology and Internal Medicine Fall Short of Nationally Recommended Readability Benchmarks in the United States.

Arthritis care & research·2024
Same author

CD11b suppresses TLR7-driven inflammatory signaling to protect against lupus nephritis.

bioRxiv : the preprint server for biology·2024
Same author

Circularly Polarized Luminescence Without External Magnetic Fields from Individual CsPbBr<sub>3</sub> Perovskite Quantum Dots.

ACS nano·2024
Same author

Assessing readability and comprehension of web-based patient education materials by American Heart Association (AHA) and CardioSmart online platform by American College of Cardiology (ACC): How useful are these websites for patient understanding?

American heart journal plus : cardiology research and practice·2024
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Asymptomatic hyperuricemia was previously treated, but evidence linking it to kidney disease is inconclusive. Recent studies prompt reevaluation of hyperuricemia

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Disorders

Background:

  • Historically, asymptomatic hyperuricemia was treated due to a perceived link with chronic kidney disease (CKD).
  • Epidemiological studies in the 1970s did not confirm hyperuricemia or gout as independent risk factors for CKD.
  • Consequently, urate-lowering therapy is not typically recommended for asymptomatic hyperuricemia.

Purpose of the Study:

  • To review the current understanding of the relationship between hyperuricemia and associated health disorders.
  • To examine the unresolved question of a causal role for hyperuricemia in CKD and other conditions.

Main Methods:

  • Review of epidemiological, experimental, and clinical studies.
  • Analysis of the current scientific literature on hyperuricemia and its associated conditions.

Related Experiment Videos

Main Results:

  • Evidence linking hyperuricemia to CKD as an independent risk factor remains inconclusive.
  • Recent research suggests a potential role for hyperuricemia in CKD, cardiovascular disease, hypertension, and metabolic syndrome, warranting further investigation.

Conclusions:

  • The causal role of hyperuricemia (with or without gout) in CKD and other disorders is still unresolved.
  • Reexamination of this relationship is ongoing, driven by recent scientific findings.